Web Analytics

Investor Profile

Rock Springs Capital

Rock Springs Capital United States - Baltimore, Maryland
INVESTOR

1 Disclosed Funding Rounds $135,000,000
6 Participating Investments




Rock Springs Capital is an investment firm that manages long-biased, healthcare-focused public equity funds.

Invested In

Company Date Round Raised
  Hemab Therapeutics February, 22 ,2023 Series B $135,000,000
  Genesis Therapeutics August, 22 ,2023 Series B $200,000,000
  Apollo Therapeutics September, 11 ,2023 Series C $226,500,000
  Avalyn Pharma Inc. September, 28 ,2023 Series C $175,000,000
  FogPharma March, 05 ,2024 Series E $145,000,000
  Arsenal Biosciences, Inc. September, 04 ,2024 Series C $325,000,000